jain.com

$700M private placement

Company: Nebius

This claim was marked delayed on September 21, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2026-09-17
Promised by
2024-12-01
Promised amount
700000000.0 USD
Current status
delayed

The claim, verbatim

Nebius raised $700 million in a private placement at $21 per share in December 2024, with buyers including Accel and Nvidia

Source (primary)

$10,000 in Nebius When It Returned to Trading in 2024 Is Worth About $105,000 Now - Yahoo Finance (-, news_article)
View cached copy (2026-09-20)Live source ↗

Quote: “In December 2024, the company raised $700 million in a private placement at $21 per share. The buyers included Accel and Nvidia”

How we checked this

Checked on September 25, 2026. The cited source supports every part of this claim.

The article states each of these details directly.

Confirmed in the source:

What we did: Read our cached copy of the publisher (https://finance.yahoo.com/markets/stocks/articles/10-000-nebius-returned-trading-165801696.html) in full (12,985 characters, retrieved September 20, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms $10,000 in Nebius When It Returned to Trading in 2024 Is Worth About $105,000 Now - Yahoo Finance

Quote: “In December 2024, the company raised $700 million in a private placement at $21 per share. The buyers included Accel and Nvidia”

View cached copy (2026-09-20)Live source ↗

Record of changes

September 20, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 21, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.